Plich Investments is a highly focused and personalized boutique strategic advisory and transaction firm dedicated to the European pharmaceutical and biotech market. We advise on both corporate- and business- development related matters such as capital raises, license agreements and M&A and other strategic alternatives. While we remain open to all corporate structures, we pride ourselves on our ability to deliver outsized value to smaller, often family-owned, enterprises, where we can have a significant impact on their ability to penetrate US, European and other international markets and help them better monetize their innovations. Our sweet spot of deal types is with niche or orphan medicines in the late-stage clinical development. In select cases, we have also invested our own capital in certain programs. Collectively, our team has 70 years industry experience and our execution confidence stems from closing most every type of pharma/biotech transaction, as both industry executives and board members. Headquartered in Amsterdam, the Netherlands, our international team includes experts based in the United States and the United Kingdom.